Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 1/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/08

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 2weeks post infection.

Abundance in Group 1: decreased abundance in Tuberculosis + isoniazid-rifampin-pyrazinamide (HRZ) (TB +HRZ group) - 2weeks(W6)

NCBI	Quality Control	Links
Acetanaerobacterium
Acetivibrio
Acidaminobacter
Alkaliphilus
Anaerovorax
Bacteroides
Butyricicoccus
Christensenella
Clostridium
Dorea
Ethanoligenens
Eubacterium
Gordonibacter
Halomonas
Marvinbryantia
Parvibacter
Pediococcus
Peptococcus
Pseudobacteroides
Robinsoniella
Romboutsia
Ruminococcus
Sporobacter
Stomatobaculum
Syntrophococcus
Turicibacter
Tyzzerella

Revision editor(s): KateRasheed